BAILRIGG IMMUNODIAGNOSTICS LIMITED
Significant control: Rashmi Mukesh (25–50%), Mukesh Kumar (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Bailrigg Immunodiagnostics Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Bailrigg Immunodiagnostics Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
BAILRIGG IMMUNODIAGNOSTICS LIMITED is an active private limited company (company number 10663923) incorporated on 10 March 2017, registered in Lancaster. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 23 September 2024, showing net assets of £6,975, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 10% on the prior period (£6,360).
By net assets it sits in the upper half of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
- Rashmi Mukesh
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mr Mukesh Kumar
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
- Rashmi Mukesh
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 10 March 20179 yrs ago
- Next accounts due
- 23 June 2026126 days overdue
- Confirmation statement due
- 24 March 2027in 148 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 23 September 2024 | £6,975 | — | — | £1,250 | — | — | 0 |
| 25 September 2023 | £6,360 | — | — | £1,765 | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £6,975 at 23 September 2024
- Current assets below creditors within one yearCurrent ratio 0.44
- Incorporated five or more years agoIncorporated 10 March 2017
- Accounts past their due dateDue 23 June 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 148 days
- Next accounts due126 days overdue
- Accounts period endNet assets £6,975 · micro accounts
- Accounts period endNet assets £6,360 · micro accounts
- Incorporated
Similar companies in Lancashire
- DRUG SAFETY LIMITEDColne · inc. Jan 2017
- IMPULSE ANALYSIS LIMITEDBlackpool · inc. Jan 2018
- NANOPORE SOLUTIONS LTDLancaster · inc. Feb 2016
- ELUCIDA HEALTH LTDNelson · inc. May 2018
- CHIRON SCIENTIFIC WRITING LIMITEDKendal · inc. Aug 2015
- CAROLINE DNA 2 LIMITEDThornton Cleveleys · inc. Oct 2018
All companies incorporated on 10 March 2017 · in Mar 2017.
Reminders for BAILRIGG IMMUNODIAGNOSTICS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.